Information required by the Food and Drug Administration Amendments Act of In general, this is a description of any agreement between the sponsor of a . Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are . Indonesia Clinical Trials listed on the CenterWatch Clinical Trials Listing Service.
Our Quality of Life Results. Quality and Patient Safety. Caring for a Loved One With Cancer. Intimacy During Cancer Care. Talking With Children About Cancer. Call us anytime Relevance Alphabetical Most Recent. Bile Duct Cancer Gallbladder Cancer.
Atlanta Chicago Philadelphia Tulsa. Learn more at clinicaltrials. Clinical trials may also compare a new treatment to a treatment that is already available.
Every clinical trial has a protocol, or action plan, for conducting the trial. The plan describes what will be done in the study, how it will be conducted, and why each part of the study is necessary.
Each study has its own rules about who can take part. Some studies need volunteers with a certain disease. Some need healthy people. Others want just men or just women. It is an independent committee of physicians, statisticians, and members of the community.
The sponsor designs the trial in coordination with a panel of expert clinical investigators, including what alternative or existing treatments to compare to the new drug and what type s of patients might benefit.
If the sponsor cannot obtain enough test subjects at one location investigators at other locations are recruited to join the study. During the trial, investigators recruit subjects with the predetermined characteristics, administer the treatment s and collect data on the subjects' health for a defined time period. Data include measurements such as vital signs , concentration of the study drug in the blood or tissues, changes to symptoms, and whether improvement or worsening of the condition targeted by the study drug occurs.
The researchers send the data to the trial sponsor, who then analyzes the pooled data using statistical tests. Examples of clinical trial goals include assessing the safety and relative effectiveness of a medication or device:. While most clinical trials test one alternative to the novel intervention, some expand to three or four and may include a placebo.
Except for small, single-location trials, the design and objectives are specified in a document called a clinical trial protocol. The protocol is the trial's "operating manual" and ensures that all researchers perform the trial in the same way on similar subjects and that the data is comparable across all subjects. As a trial is designed to test hypotheses and rigorously monitor and assess outcomes, it can be seen as an application of the scientific method , specifically the experimental step.
The most common clinical trials evaluate new pharmaceutical products , medical devices such as a new catheter , biologics , psychological therapies , or other interventions. Clinical trials may be required before a national regulatory authority  approves marketing of the innovation. Similarly to drugs, manufacturers of medical devices in the United States are required to conduct clinical trials for premarket approval.
An example of the former in the field of vascular surgery is the Open versus Endovascular Repair OVER trial for the treatment of abdominal aortic aneurysm , which compared the older open aortic repair technique to the newer endovascular aneurysm repair device. Similarly to drugs, medical or surgical procedures may be subjected to clinical trials,  such as case-controlled studies for surgical interventions.
The concepts behind clinical trials are ancient. The Book of Daniel chapter 1, verses 12 through 15, for instance, describes a planned experiment with both baseline and follow-up observations of two groups who either partook of, or did not partake of, "the King's meat" over a trial period of ten days. Persian physician Avicenna , in The Canon of Medicine gave similar advice for determining the efficacy of medical drugs and substances. Although early medical experimentation was often performed, the use of a control group to provide an accurate comparison for the demonstration of the intervention's efficacy, was generally lacking.
For instance, Lady Mary Wortley Montagu , who campaigned for the introduction of inoculation then called variolation to prevent smallpox , arranged for seven prisoners who had been sentenced to death to undergo variolation in exchange for their life. Although they survived and did not contract smallpox, there was no control group to assess whether this result was due to the inoculation or some other factor. Similar experiments performed by Edward Jenner over his smallpox vaccine were equally conceptually flawed.
The first proper clinical trial was conducted by the physician James Lind. In , the catastrophic result of Anson 's circumnavigation attracted much attention in Europe; out of men, had died, most of them allegedly from having contracted scurvy.
Lind conducted the first systematic clinical trial in He divided twelve scorbutic sailors into six groups of two. They all received the same diet but, in addition, group one was given a quart of cider daily, group two twenty-five drops of elixir of vitriol sulfuric acid , group three six spoonfuls of vinegar , group four half a pint of seawater, group five received two oranges and one lemon , and the last group a spicy paste plus a drink of barley water.
The treatment of group five stopped after six days when they ran out of fruit, but by that time one sailor was fit for duty while the other had almost recovered. Apart from that, only group one also showed some effect of its treatment. After , the discipline began to take its modern shape. Further work in that direction was carried out by the eminent physician Sir William Gull, 1st Baronet in the s. Frederick Akbar Mahomed d. He also founded the Collective Investigation Record for the British Medical Association ; this organization collected data from physicians practicing outside the hospital setting and was the precursor of modern collaborative clinical trials.
Fisher , while working for the Rothamsted experimental station in the field of agriculture, developed his Principles of experimental design in the s as an accurate methodology for the proper design of experiments. Among his major ideas, was the importance of randomization — the random assignment of individuals to different groups for the experiment;  replication — to reduce uncertainty , measurements should be repeated and experiments replicated to identify sources of variation;  blocking — to arrange experimental units into groups of units that are similar to each other, and thus reducing irrelevant sources of variation; use of factorial experiments — efficient at evaluating the effects and possible interactions of several independent factors.
The British Medical Research Council officially recognized the importance of clinical trials from the s. The Council established the Therapeutic Trials Committee to advise and assist in the arrangement of properly controlled clinical trials on new products that seem likely on experimental grounds to have value in the treatment of disease.
The trial, carried out between —, aimed to test the efficacy of the chemical streptomycin for curing pulmonary tuberculosis. The trial was both double-blind and placebo-controlled.
The methodology of clinical trials was further developed by Sir Austin Bradford Hill , who had been involved in the streptomycin trials. From the s, Hill applied statistics to medicine, attending the lectures of renowned mathematician Karl Pearson , among others. He became famous for a landmark study carried out in collaboration with Richard Doll on the correlation between smoking and lung cancer. They carried out a case-control study in , which compared lung cancer patients with matched control and also began a sustained long-term prospective study into the broader issue of smoking and health, which involved studying the smoking habits and health of over 30, doctors over a period of several years.
His certificate for election to the Royal Society called him " International clinical trials day is celebrated on 20 May. Another way of classifying trials is by their purpose. A third classification is whether the trial design allows changes based on data accumulated during the trial. Finally, a common way of distinguishing trials is by phase, which in simple terms, relates to how close the drug is to being clinically proven both effective for its stated purpose and accepted by the regulatory authorities for use for that purpose.
Clinical trials involving new drugs are commonly classified into five phases. Each phase of the drug approval process is treated as a separate clinical trial. The drug-development process will normally proceed through all four phases over many years. If the drug successfully passes through phases 1, 2, and 3, it will usually be approved by the national regulatory authority for use in the general population. Before pharmaceutical companies start clinical trials on a drug, they will also have conducted extensive preclinical studies.
Each phase has a different purpose and helps scientists answer a different question. A fundamental distinction in evidence-based practice is between observational studies and randomized controlled trials. A randomized controlled trial can provide compelling evidence that the study treatment causes an effect on human health.
Currently, some phase 2 and most phase 3 drug trials are designed as randomized, double-blind , and placebo -controlled. Clinical studies having small numbers of subjects may be "sponsored" by single researchers or a small group of researchers, and are designed to test simple questions or feasibility to expand the research for a more comprehensive randomized controlled trial.
In many cases, giving a placebo to a person suffering from a disease may be unethical. In trials with an active control group, subjects are given either the experimental treatment or a previously approved treatment with known effectiveness. In such studies, multiple experimental treatments are tested in a single trial. Genetic testing enables researchers to group patients according to their genetic profile, deliver drugs based on that profile to that group and compare the results.
Multiple companies can participate, each bringing a different drug. The first such approach targets squamous cell cancer , which includes varying genetic disruptions from patient to patient. Amgen, AstraZeneca and Pfizer are involved, the first time they have worked together in a late-stage trial.
Patients whose genomic profiles do not match any of the trial drugs receive a drug designed to stimulate the immune system to attack cancer. A clinical trial protocol is a document used to define and manage the trial.
It is prepared by a panel of experts. All study investigators are expected to strictly observe the protocol. The protocol describes the scientific rationale, objective s , design, methodology, statistical considerations and organization of the planned trial.
Details of the trial are provided in documents referenced in the protocol, such as an investigator's brochure. The protocol contains a precise study plan to assure safety and health of the trial subjects and to provide an exact template for trial conduct by investigators.
The protocol also informs the study administrators often a contract research organization. The format and content of clinical trial protocols sponsored by pharmaceutical, biotechnology or medical device companies in the United States, European Union, or Japan have been standardized to follow Good Clinical Practice guidance  issued by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH. Journals such as Trials , encourage investigators to publish their protocols.
Clinical trials recruit study subjects to sign a document representing their " informed consent ". The document is not a contract, as the participant can withdraw at any time without penalty. Informed consent is a legal process in which a recruit is instructed about key facts before deciding whether to participate.
Researchers explain the details of the study in terms the subject can understand. The information is presented in the subject's native language. Generally, children cannot autonomously provide informed consent, but depending on their age and other factors, may be required to provide informed assent.
The number of subjects has a large impact on the ability to reliably detect and measure effects of the intervention. This is described as its " power ". The larger the number of participants, the greater the statistical power and the greater the cost.
The statistical power estimates the ability of a trial to detect a difference of a particular size or larger between the treatment and control groups. For example, a trial of a lipid -lowering drug versus placebo with patients in each group might have a power of 0. Merely giving a treatment can have nonspecific effects. These are controlled for by the inclusion of patients who receive only a placebo.
Subjects are assigned randomly without informing them to which group they belonged. Many trials are doubled-blinded so that researchers do not know to which group a subject is assigned. Assigning a subject to a placebo group can pose an ethical problem if it violates his or her right to receive the best available treatment. The Declaration of Helsinki provides guidelines on this issue. Clinical trials are only a small part of the research that goes into developing a new treatment.
Potential drugs, for example, first have to be discovered, purified, characterized, and tested in labs in cell and animal studies before ever undergoing clinical trials. In all, about 1, potential drugs are tested before just one reaches the point of being tested in a clinical trial. But the major holdup in making new cancer drugs available is the time it takes to complete clinical trials themselves.
On average, about eight years pass from the time a cancer drug enters clinical trials until it receives approval from regulatory agencies for sale to the public. The biggest barrier to completing studies is the shortage of people who take part. All drug and many device trials target a subset of the population, meaning not everyone can participate. Some drug trials require patients to have unusual combinations of disease characteristics.
It is a challenge to find the appropriate patients and obtain their consent, especially when they may receive no direct benefit because they are not paid, the study drug is not yet proven to work, or the patient may receive a placebo.
Not all of these will prove to be useful, but those that are may be delayed in getting approved because the number of participants is so low. For clinical trials involving potential for seasonal influences such as airborne allergies , seasonal affective disorder , influenza , and skin diseases , the study may be done during a limited part of the year such as spring for pollen allergies , when the drug can be tested.
Clinical trials that do not involve a new drug usually have a much shorter duration. Exceptions are epidemiological studies, such as the Nurses' Health Study.
Clinical trials designed by a local investigator, and in the US federally funded clinical trials, are almost always administered by the researcher who designed the study and applied for the grant. Small-scale device studies may be administered by the sponsoring company. Clinical trials of new drugs are usually administered by a contract research organization CRO hired by the sponsoring company.
The sponsor provides the drug and medical oversight. A CRO is contracted to perform all the administrative work on a clinical trial. For phases 2, 3 and 4, the CRO recruits participating researchers, trains them, provides them with supplies, coordinates study administration and data collection, sets up meetings, monitors the sites for compliance with the clinical protocol, and ensures the sponsor receives data from every site. Phase 1 clinical trials of new medicines are often conducted in a specialist clinical trial clinic, with dedicated pharmacologists, where the subjects can be observed by full-time staff.
These clinics are often run by a CRO which specialises in these studies. At a participating site, one or more research assistants often nurses do most of the work in conducting the clinical trial.
The research assistant's job can include some or all of the following: Janet Yang uses the Interactional Justice Model to test the effects of willingness to talk with a doctor and clinical trial enrollment.
Search for Clinical Trials
Clinical trials are medical studies that involve people like you. Learn more about what to expect, NHLBI's role in clinical trials, and how you can get involved. Interested in clinical research? Learn about the difference between clinical studies and clinical trials, and the phases of clinical trials for FDA approval. Did you ever wonder how doctors find out if a treatment is effective? Clinical trials test how well new medical approaches work in people.